Protracted and variable latency of acute lymphoblastic leukemia after TEL-AML1 gene fusion in utero
Protracted and variable latency of acute lymphoblastic leukemia after TEL-AML1 gene fusion in utero
复制标题
DOI:
10.1182/blood.v94.3.1057.415k10_1057_1062
复制
发表时间:
1999-08-01
期刊:
影响因子:
20.3
通讯作者:
Greaves, M
中科院分区:
文献类型:
--
作者:
Wiemels, JL;Ford, AM;Greaves, M
We report a pair of identical twins with concordant acute lymphoblastic leukemia (ALL). Unusually, their diagnoses were spaced 9 years apart at ages 5 and 14, Leukemic cells in both twins had a TEL-AML1 rearrangement, which was characterized at the DNA level by an adaptation of a long distance polymerase chain reaction (PCR) method. The genomic fusion sequence was identical in the two leukemias, indicative of a single cell origin in one fetus, in utero. At the time twin 1 was diagnosed (aged 5 years), the bone marrow of twin 2 was hematologically normal. However, retrospective scrutiny of the DNA from an archived slide with clonotypic TEL-AML1 primers showed that the presumptive preleukemic clone was present and disseminated 9 years before a clinical diagnosis. These data provide novel insight into the natural history of childhood leukemia and suggest that consequent to a prenatal initiation of a leukemic clone, most probably by TEL-AML fusion itself, the latency of ALL can be both extremely variable and protracted. This, in turn, is likely to reflect the timing of critical secondary events. (C) 1999 by The American Society of Hematology.